|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 412 1st Street, SE |
Address2 | Suite 3 |
City | Washington |
State | DC |
Zip Code | 20003 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 400660986-24
|
||||||||
|
6. House ID# 414350000
|
TYPE OF REPORT | 8. Year | 2017 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: G. David Mason |
Date | 7/20/2017 10:22:32 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Legislation and policies related to:
Physician/nurse practitioner reimbursement
Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148)
Implementation of the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015 (P.L. 114-10) including policies related to the Quality Payment Program
Adoption of recommendations of the Institute of Medicine report, The Future of Nursing: Leading Change, Advancing Health
Medicare Shared Savings Program beneficiary assignment requirements
Medicare-Medicaid hospital conditions of participation
Evaluation of the Medicare Graduate Nurse Education demonstration
Medicare-Medicaid Program Integrity policies
Medicaid maintenance of effort requirements
Medicaid eligibility expansion and state options
Medicaid waiver application procedures
Medicaid per capita cap policy options
H.R. 1160 - ACO Assignment Improvement Act of 2017
H.R. 1617 - Promoting Access to Diabetic Shoes Act
H.R. 1628 - American Health Care Act of 2017
H.R. 2688 - Incentivizing Medicaid Expansion Act
S. 191 - Patient Freedom Act
S. 222/H.R. 1072 - Obamacare Replacement Act
S. 403/H.R. 1175 - Health Savings Act of 2017
S. 445/H.R. 1825 - Home Health Care Planning Improvement Act of 2017
S. 428 - Advancing Care for Exceptional Kids (ACE Kids) Act
S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017
S. 1227/H.R. 2628 - Stabilize Medicaid and CHIP Coverage Act of 2017
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Legislation and policies relating to:
Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148)
Discussion drafts of the Better Care Reconciliation Act
Reauthorization of funding for the Childrens Health Insurance Program
Reauthorization of the Child Nutrition Act
Section 2706 of the ACA regarding provider non-discrimination
Policies related to health insurance market stabilization
Policies affecting nurse practitioner education and workforce
Definition, evaluation and enforcement of essential health benefits and provider network adequacy
Health information technology and electronic health records
Mental health services and violence prevention
Lead contamination of drinking water
H.R. 251 - Family First Prevention Services Act of 2017
H.R. 315/S. 783 - Improving Access to Maternity Care Act
H.R. 767/S. 256 - Stop, Observe, Ask, and Respond (SOAR) to Health and Wellness Act of 2017
H.R. 772/S. 261 - Common Sense Nutrition Disclosure Act
H.R. 959/S. 1109 - Title VIII Nursing Workforce Reauthorization Act of 2017
H.R. 1174/S. 1497 - Fairness For Breastfeeding Mothers Act of 2017
H.R. 1215 - Protecting Access to Care Act of 2017
H.R. 1267/S. 482 - Personal Health Investment Today (PHIT) Act of 2017
H.R. 1313 - Preserving Employee Wellness Programs Act
H.R. 2579 - Broader Options for Americans Act
H.R. 1671/H.R. 2581 - Verify First Act
H.R. 2742/S. 1257 - Modernizing the Interstate Placement of Children in Foster Care Act
H.R. 2824 - Increasing Opportunity through Evidence-Based Home Visiting Act
H.R. 2857 - Supporting Families in Substance Abuse Treatment Act
H.R. 2834 - Partnership Grants to Strengthen Families Affected by Parental Substance Abuse Act
H.R. 2866 - Reducing Barriers for Relative Foster Parents Act
H.R. 2847 - Improving Services for Older Youth in Foster Care Act
S. 761/H.R. 1933 - Health Care Options Act of 2017
S. 1016/H.R. 2556 - Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2017
S. 1028 - Recognize, Assist, Include, Support, and Engage (RAISE) Family Caregivers Act
S. 1091/H.R. 3105 - Supporting Grandparents Raising Grandchildren Act
S. 1268 - Child Protection and Family Support Act of 2017
S.1377 - Reaching Underserved Rural Areas to Lead on Telehealth Act
S. 1441/H.R. 3059 - Community Health Center and Primary Care Workforce Expansion Act of 2017
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Legislation and policies relating to:
Authorization and appropriations of Title VIII funding for nurse education and nurse workforce development programs in fiscal years 2017 and 2018
FY 2017 and 2018 appropriations for antimicrobial research programs
FY 2017 and 2018 appropriations for the Childrens Hospitals Graduate Medical Education Program
FY 2017 and 2018 appropriations for the FDA Pediatric Device Consortia Grant Program
Impact of sequestration on the Health Resources and Services Administration (HRSA) and other discretionary Department of Health and Human Services spending
H.R. 244 - Consolidated Appropriations Act, 2017
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
Legislation and policies related to:
Reform of procedures for developing, publishing, commenting on and enforcement of federal regulations, guidance and policies
H.R. 5/S. 951 - Regulatory Accountability Act of 2017
H.R. 21/S. 34 - Midnight Rules Relief Act of 2017
H.R. 26/S. 21 - Regulations from the Executive In Need of Scrutiny (REINS) Act of 2017
H.R. 77/S. 577 - Providing Accountability through Transparency Act
S. 579 - Early Participation in Regulations Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Legislation and policies related to:
Pediatric and childrens health research
Nursing research
Draft legislation to reauthorize and modernize the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act
H.R. 2430/S. 934 - FDA Reauthorization Act of 2017
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Legislation and policies related to:
Draft legislation to reauthorize and modernize the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act
H.R. 749 - Lower Drug Costs through Competition Act
S. 297 - Increasing Competition in Pharmaceuticals Act
S. 771/H.R. 1776 - Improving Access to Affordable Prescription Drugs Act
S. 892 - Opioid Addiction Prevention Act of 2017
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Legislation and policies relating to:
Revision and implementation of Department of Veterans Affairs regulation RIN 2900-AP44, Advanced Practice Registered Nurses
H.R. 1783 - Improving Veterans Access to Quality Care Act of 2017
H.R. 2547 - Veterans Expanded Trucking Opportunities Act of 2017
S. 544 - To amend the Veterans Access, Choice, and Accountability Act of 2014 to modify the termination date for the Veterans Choice Program
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |